Niagen Bioscience (NAGE) Beginning Cash Balance (2012 - 2018)

Niagen Bioscience (NAGE) has 7 years of Beginning Cash Balance data on file, last reported at $45.4 million in Q1 2018.

• On a quarterly basis, Beginning Cash Balance rose 2664.25% year-over-year to $45.4 million in Q1 2018; TTM through Mar 2018 was $47.0 million, a 553.97% increase from a year earlier, with the FY2013 full-year figure at $520000.0, up 23.76% from the prior year.
• Beginning Cash Balance for Q1 2018 stood at $45.4 million, up from $429.0 in the prior quarter.
• Over the last five years, Beginning Cash Balance for NAGE reached as high as $45.4 million in Q1 2018 and fell as low as $429.0 in Q3 2017.
• Historically, Beginning Cash Balance has averaged $9.8 million across 5 years, with a median of $3.1 million in 2014.
• Across the five-year window, Beginning Cash Balance plunged 70.41% in 2017 and surged 2664.25% in 2018, its largest moves.
• Year by year, Beginning Cash Balance stood at $2.3 million in 2014, then surged by 75.33% to $4.0 million in 2015, then surged by 39.98% to $5.5 million in 2016, then slumped by 99.99% to $429.0 in 2017, then surged by 10580086.48% to $45.4 million in 2018.
• Per Business Quant data, the three most recent Beginning Cash Balance figures were $45.4 million in Q1 2018, $429.0 in Q3 2017, and $1.6 million in Q2 2017.